Starting from the small
percentage of proteins of known structure, homology modelling and structure
prediction technology build usable structural models for up to 30-50%
of all proteins. The models can be used for decision support in drug
discovery, e.g. prioritizing targets by 'drugability', for docking and
virtual ligand screening, for directing chemistry in lead optimization.